Suchen
Simulations Plus Inc
SLPZur Watchlist hinzufügen
13.340USD
-0.040-0.30%
Handelsschluss 05/15, 16:00（ET）Kurse um 15 Minuten verzögert
269.54MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Simulations Plus Inc Unternehmen
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
Simulations Plus Inc Informationen
BörsenkürzelSLP
Name des UnternehmensSimulations Plus Inc
IPO-datumJun 18, 1997
CEOO'Connor (Shawn M)
Anzahl der mitarbeiter212
WertpapierartOrdinary Share
GeschäftsjahresendeJun 18
Addresse800 Park Offices Drive, Suite 401
StadtRESEARCH TRIANGLE PARK
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl27709
Telefon16617237723
Websitehttps://www.simulations-plus.com/
BörsenkürzelSLP
IPO-datumJun 18, 1997
CEOO'Connor (Shawn M)
Führungskräfte von Simulations Plus Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.27M
-0.39%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
77.82K
+11.50%
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
17.17K
+12.33%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
14.59K
+14.51%
Mr. John A. Dibella
Mr. John A. Dibella
Chief Revenue Officer
Chief Revenue Officer
--
--
Dr. Daniel L. Weiner
Dr. Daniel L. Weiner
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Mr. Shawn M. O'Connor
Mr. Shawn M. O'Connor
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Lisa Lavange
Dr. Lisa Lavange
Independent Director
Independent Director
--
--
Mr. William (Will) Frederick
Mr. William (Will) Frederick
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Dr. Jonathan Chauvin
Dr. Jonathan Chauvin
Co-Chief Product and Technology Officer
Co-Chief Product and Technology Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.27M
-0.39%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
77.82K
+11.50%
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
17.17K
+12.33%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
14.59K
+14.51%
Mr. John A. Dibella
Mr. John A. Dibella
Chief Revenue Officer
Chief Revenue Officer
--
--
Dr. Daniel L. Weiner
Dr. Daniel L. Weiner
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Apr 6
Währung: USDAktualisiert: Mon, Apr 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Consulting services
9.54M
51.78%
Software licenses
8.88M
48.22%
Nach RegionUSD
Name
Umsatz
Anteil
Americas
13.45M
72.99%
Europe
3.13M
17.02%
Asia
1.84M
9.99%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Consulting services
9.54M
51.78%
Software licenses
8.88M
48.22%
Aktionärsstatistik
Aktualisiert: Sun, May 10
Aktualisiert: Sun, May 10
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Woltosz (Walter S)
16.17%
First Light Asset Management, LLC
13.11%
BlackRock Institutional Trust Company, N.A.
5.38%
Vanguard Capital Management, LLC
3.66%
Marshall Wace LLP
2.82%
Andere
58.85%
Aktionäre
Aktionäre
Anteil
Woltosz (Walter S)
16.17%
First Light Asset Management, LLC
13.11%
BlackRock Institutional Trust Company, N.A.
5.38%
Vanguard Capital Management, LLC
3.66%
Marshall Wace LLP
2.82%
Andere
58.85%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
33.24%
Investment Advisor/Hedge Fund
31.94%
Individual Investor
17.29%
Hedge Fund
8.07%
Research Firm
7.46%
Pension Fund
1.31%
Bank and Trust
0.42%
Family Office
0.08%
Insurance Company
0.03%
Andere
0.15%
Institutionelle Beteiligung
Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
432
17.68M
87.48%
-4.63M
2025Q4
414
15.97M
79.29%
-4.03M
2025Q3
399
15.45M
76.77%
-3.13M
2025Q2
397
20.10M
99.87%
-2.39M
2025Q1
405
20.80M
103.44%
-1.07M
2024Q4
395
19.75M
98.32%
-353.54K
2024Q3
400
19.32M
96.55%
-155.06K
2024Q2
401
20.11M
100.50%
-787.76K
2024Q1
398
20.05M
100.34%
-310.16K
2023Q4
390
19.56M
97.97%
-570.84K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Woltosz (Walter S)
3.28M
16.28%
-9.10K
-0.28%
Dec 18, 2025
First Light Asset Management, LLC
767.76K
3.81%
+410.60K
+114.96%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.06M
5.29%
-1.18M
-52.66%
Sep 30, 2025
Marshall Wace LLP
250.48K
1.24%
+117.20K
+87.94%
Sep 30, 2025
Morgan Stanley & Co. LLC
832.51K
4.13%
+582.97K
+233.61%
Sep 30, 2025
Rockefeller Capital Management
745.96K
3.7%
+366.80K
+96.74%
Sep 30, 2025
Tributary Capital Management, LLC
568.49K
2.82%
+207.21K
+57.36%
Sep 30, 2025
First Eagle Investment Management, L.L.C.
457.15K
2.27%
+434.27K
+1898.06%
Dec 31, 2025
Royce Investment Partners
348.76K
1.73%
+83.76K
+31.61%
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Tue, Dec 2
Aktualisiert: Tue, Dec 2
Name
Anteil
State Street SPDR FactSet Innovative Technolgy ETF
0.58%
Global X HealthTech ETF
0.31%
First Trust Active Factor Small Cap ETF
0.28%
First Trust Multi-Manager Small Cap Opportunities ETF
0.21%
Franklin Exponential Data ETF
0.12%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.09%
Principal U.S. Small-Cap ETF
0.07%
iShares Micro-Cap ETF
0.06%
iShares Russell 2000 Growth ETF
0.02%
Proshares Ultra Russell 2000
0.01%
Mehr Anzeigen
State Street SPDR FactSet Innovative Technolgy ETF
Anteil0.58%
Global X HealthTech ETF
Anteil0.31%
First Trust Active Factor Small Cap ETF
Anteil0.28%
First Trust Multi-Manager Small Cap Opportunities ETF
Anteil0.21%
Franklin Exponential Data ETF
Anteil0.12%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Anteil0.09%
Principal U.S. Small-Cap ETF
Anteil0.07%
iShares Micro-Cap ETF
Anteil0.06%
iShares Russell 2000 Growth ETF
Anteil0.02%
Proshares Ultra Russell 2000
Anteil0.01%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
19.26M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Jul 02, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 05, 2024 going ex on Jul 29, 2024
Jul 29, 2024
Aug 05, 2024
Jul 29, 2024
Apr 03, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 06, 2024 going ex on Apr 26, 2024
Apr 29, 2024
May 06, 2024
Apr 26, 2024
Jan 03, 2024
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Feb 05, 2024 going ex on Jan 26, 2024
Jan 29, 2024
Feb 05, 2024
Jan 26, 2024
Oct 25, 2023
SLP.NB Final Cash Dividend of gross USD 0.06 paid on Nov 06, 2023 going ex on Oct 27, 2023
Oct 30, 2023
Nov 06, 2023
Oct 27, 2023
Jul 06, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 07, 2023 going ex on Jul 28, 2023
Jul 31, 2023
Aug 07, 2023
Jul 28, 2023
Apr 06, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 01, 2023 going ex on Apr 21, 2023
Apr 24, 2023
May 01, 2023
Apr 21, 2023
Jan 05, 2023
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Feb 06, 2023 going ex on Jan 27, 2023
Jan 30, 2023
Feb 06, 2023
Jan 27, 2023
Oct 20, 2022
SLP.NB Final Cash Dividend of gross USD 0.06 paid on Nov 07, 2022 going ex on Oct 28, 2022
Oct 31, 2022
Nov 07, 2022
Oct 28, 2022
Jul 07, 2022
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on Aug 01, 2022 going ex on Jul 22, 2022
Jul 25, 2022
Aug 01, 2022
Jul 22, 2022
Apr 06, 2022
SLP.NB Interim Cash Dividend of gross USD 0.06 paid on May 02, 2022 going ex on Apr 22, 2022
Apr 25, 2022
May 02, 2022
Apr 22, 2022
Mehr Anzeigen
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
